About the Company. . . We are a stealth biotech company co-founded by two deeply scientific Bay Area venture capital teams that have impressive track records of creating successful outcomes. We are leveraging proprietary technology created at another co-funded portfolio company that enables us to develop patient-specific immunotherapy focused on solid tumors. . . Our approach deploys key de-risked licensed technology to address and solve exis...
About the Company. . We are a stealth biotech company co-founded by two deeply scientific Bay Area venture capital teams that have impressive track records of creating successful outcomes. We are leveraging proprietary technology created at another co-funded portfolio company that enables us to develop patient-specific immunotherapy focused on solid tumors. . Our approach deploys key de-risked licensed technology to address and solve existing is...
About the Company. . We are a stealth biotech company co-founded by two deeply scientific Bay Area venture capital teams that have impressive track records of creating successful outcomes. We are leveraging proprietary technology created at another co-funded portfolio company that enables us to develop patient-specific immunotherapy focused on solid tumors. . Our approach deploys key de-risked licensed technology to address and solve existing is...
We are a new company founded around a proprietary technology to develop patient specific immunotherapy focused on solid tumors. The company will grow rapidly over the next year with the goal of being in the clinic within 2 years, backed by a strong foundation of VC teams. Our approach deploys key de-risked licensed technology to address and solve existing issues of cell therapy for solid tumor patients. We are building a manufacturing first cultu...
We are a new company, currently in stealth mode, founded around a proprietary technology to develop patient specific immunotherapy focused on solid tumors. The company will grow rapidly over the next year with the goal of being in the clinic within 2 years, backed by a strong foundation of VC team Our approach deploys key de-risked licensed technology to address and solve existing issues of cell therapy for solid tumor patients. We are building a...
